CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …
Centogene öffnet seine Labore für Coronatests
Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spur ist, öffnet seine Labore für lebensrettende Coronatests. Bis zu 10.000 Abstriche können pro Tag …
Panthera employees in Quebec City have been hard at work manufacturing various prototypes of equipment designed to protect caregivers
(Montreal, March 24, 2020) Across Quebec, 3D printing companies are active in the fight against the Coronavirus. Stéphane Blais The Canadian Press They make prototypes of masks and visors; …
Centogene Announces Commencement of Testing for COVID-19
Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (GLOBAL NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical …
La Presse: “Laurent Duvernay-Tardif’s knees at their best thanks to a “knee kinesiography with KneeKG” by EMOVI
"Unless he is injured during the game on Sunday, Laurent Duvernay-Tardif will be solid on both knees when he blocks to protect Patrick Mahomes, the Kansas City Chiefs quarterback, in order to allow …
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
Accelerating new rare disease therapies through collaboration agreement Cambridge, MA, USA & Rostock/Berlin, GERMANY,13 November 2019 – CENTOGENE (Nasdaq: CNTG),commercial-stage company …
Centogene AG Rings The Nasdaq Stock Market Closing Bell in Celebration of its IPO
…
CENTOGENE Announces Proposed Initial Public Offering of Common Shares
October 28, 2019 at 8:53 AM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare …
Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma’s Phase 1 Study of AP-101 for the Treatment of ALS
Schlieren, Switzerland – October 16, 2019 – AL-S Pharma AG, a biotech company jointly founded and financed by Neurimmune and TVM Capital Life Science, announced today enrollment of the first patient …